1 |
W.E. Evans and M.V. Relling, Pharmacogenomics: translating functional genomics into rational therapeutics, Science, 286, 487 (1999)
DOI
ScienceOn
|
2 |
B. Chowbay, S. Cumaraswamy, Y.B. Cheung, Q. Zhou and E.J.D, Lee, Genetic polymorphisms in MDR1 and CYP3A4 genes in Asians and the influence of MDR1 haplotypes in cyclosporin disposition in heart transplant recipients, Pharmacogenetics, 13, 89-95 (2003)
DOI
|
3 |
http://www.people.fas.harvard.edu/~junliu/plem/click.html
|
4 |
S. Hoffmeyer, O. Burk, O. von Richter, Arnold, J. Brockmoller, A. Johne, I. Cascorbi, T. Gerloff, I. Roots, M. Eichelbaum and U. Brinkmann, Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo, Proc Natl. Acad. Sci. USA, 97, 3473-3478 (2000)
DOI
ScienceOn
|
5 |
S.W. Kim, J.W. Kim, K.A. Lee, EM 알고리듬을 이용한 단일 염기변이(SNP ; single nucleotide polymorphism)군의 일배체 형(haplotype) 비율 추정. 응용통계연구, 16(2), 195-202 (2003)
|
6 |
J. Licinio., M-L. Wong., 약물유전체학-SNP에서 맞춤약까지-, 35-56 (2004)
|
7 |
http://www.ngri.re.kr/HapAnalyzer/right.html
|
8 |
K. Tang, S.M. Ngoi, P.C. Gwee, J.M.Z. Chua, E.J.D. Lee, S.S. Chong and C.G.L. Lee, Distinct haplotype profiles and strong linkage disequilibrium at the MDR1 multidrug transporter gene locus in three ethnic Asian populations,Pharmacogenetics, 12, 437-450 (2002)
DOI
|
9 |
W. Siegmund, K. Ludwig, T. Giessmann, P. Dazert, E. Schroeder, B. Sperker, F. Warzok, H.K. Kroemer and I. Cascorbi, The effects of the human MDR1 genotype on the expression of duodenal P-glycoprotein and disposition of the probe drug talinolo, Clin. Pharmacol. Ther., 72, 572-583 (2002)
DOI
ScienceOn
|